| 000 | 01872 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516174847.0 | ||
| 264 | 0 | _c20140805 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0077523 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLuo, Hong-Min | |
| 245 | 0 | 0 |
_aValproic acid treatment inhibits hypoxia-inducible factor 1α accumulation and protects against burn-induced gut barrier dysfunction in a rodent model. _h[electronic resource] |
| 260 |
_bPloS one _c2013 |
||
| 300 |
_ae77523 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylation _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBurns _xcomplications |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aGastroenteritis _xdrug therapy |
| 650 | 0 | 4 |
_aHistones _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyosin-Light-Chain Kinase _xmetabolism |
| 650 | 0 | 4 |
_aPermeability _xdrug effects |
| 650 | 0 | 4 |
_aProtective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aValproic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 650 | 0 | 4 |
_aZonula Occludens-1 Protein _xmetabolism |
| 700 | 1 | _aDu, Ming-Hua | |
| 700 | 1 | _aLin, Zhi-Long | |
| 700 | 1 | _aZhang, Lin | |
| 700 | 1 | _aMa, Li | |
| 700 | 1 | _aWang, Huan | |
| 700 | 1 | _aYu, Wen | |
| 700 | 1 | _aLv, Yi | |
| 700 | 1 | _aLu, Jiang-Yang | |
| 700 | 1 | _aPi, Yu-Li | |
| 700 | 1 | _aHu, Sen | |
| 700 | 1 | _aSheng, Zhi-Yong | |
| 773 | 0 |
_tPloS one _gvol. 8 _gno. 10 _gp. e77523 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0077523 _zAvailable from publisher's website |
| 999 |
_c23190988 _d23190988 |
||